H.C. Wainwright maintains $75 target on Corbus stock
H.C. Wainwright analyst Andres Y. Maldonado confirmed a Buy rating and a $75.00 price target on Corbus Pharmaceuticals (NASDAQ:CRBP), representing significant upside potential from the current price ...
PharmiWeb16h
Libtayo® (cemiplimab) Now Available on the National Health Service in Scotland for Patients with Recurrent or Metastatic Cervical Cancer
Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...
Most Common Cancers And Prevention
Find Most Common Cancers And Prevention Latest News, Videos & Pictures on Most Common Cancers And Prevention and see latest updates, news, information from NDTV.COM. Explore more on Most Common ...
Cervical cancer meant I needed a hysterectomy at 24. Now I’m grieving the children I’ll never carry
Sierra Boughton's doctor insisted her heavy, painful periods were normal, but then at just 24, she received devastating news.